Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 21.
Vivus promotes COO to president
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Vivus Inc. promoted Peter Tam, its chief operating officer, to president. (XOMA) (VVUS)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 3, 2009 Category: Pharmaceuticals Source Type: journals
Advanced Medical Isotope Corporation Receives Positive Results from Initial Tests of a Proprietary and Innovative Method for the Domestic Production of Molybdenum-99Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
KENNEWICK, Wash., Nov. 3, 2009 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (Pinks Sheets:ADMD) (www.isotopeworld.com), a company engaged in the production and distribution of medical isotopes, is delighted to announce the encouraging results from initial tests conducted at Idaho State University (Pocatello, Idaho) in conjunction with researchers from the University of Missouri (Columbia, Missouri).
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
Rigel reports $26.7M loss in Q3Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In the third quarter ended September, Rigel Pharmaceuticals Inc. lost $26.7 million, down from a loss of $37.7 million in the same quarter a year earlier. (RIGL)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 3, 2009 Category: Pharmaceuticals Source Type: journals
NanoLogix Inc.: NanoLogix Files International Patent Applications, Reclaims 18 Existing Patents, Noted in Department of Defense Quarterly Publication and Provides Operations UpdateEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HUBBARD, OH (MARKET WIRE) NanoLogix, Inc. (PINKSHEETS: NNLX) announces that the company has recently filed BNP™ (BioNanoPore) national patent applications in China, Japan, India, Brazil, Russia and the EU. These applications were filed in order to obtain intellectual property protection for the company's technology in countries viewed as representing the largest potential international market for BNP rapid detection, a revolutionary sandwiched-membrane Petri-based technology that can reduce microorganism detection times by 100-400%.
Source: Market Wire - Pharmaceuticals and Biotech - November 3, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare NNLX Source Type: news
Brookdale curbs losses in 3QEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Brookdale Senior Living Inc. reported a loss in the third quarter, but still showed improvement over the same period last year. (BKD)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 3, 2009 Category: Pharmaceuticals Source Type: journals
N.C. workers’ comp premiums to drop 9.6%Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Businesses in North Carolina will pay less for workers’ compensation insurance next year, according to the N.C. Department of Insurance.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 3, 2009 Category: Pharmaceuticals Source Type: journals
Ambrilia Biopharma Inc.: Ambrilia Biopharma Provides Bi-Weekly Status UpdateEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MONTREAL, QUEBEC (MARKET WIRE) Ambrilia Biopharma Inc. (TSX: AMB) is providing today its bi-weekly Default Status Report under National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("Default Status Report").
Source: Market Wire - Pharmaceuticals and Biotech - November 3, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech AMB Source Type: news
Cutting Edge Information: Pharmaceutical Speaker Programs an Important Source of Medical Education, Says Cutting Edge InformationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RESEARCH TRIANGLE PARK, NC (MARKET WIRE) Like many other marketing activities within the industry, pharmaceutical speaker programs -- and the physician-industry relationships that they consist of -- are under attack, most recently by the Boston Globe.
Source: Market Wire - Pharmaceuticals and Biotech - November 3, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
J&J to Cut Up to 7% of Work ForceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Johnson & Johnson announced plans to lay off as many as 8,400 employees worldwide -- 7%of its work force -- as part of a move to save up to $1.7 billion in 2011.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
IPOdesktop.com Internet Radio Series Interviews Orthopedic Surgeon Dr. Eugene Wolf, Who Sees Multiple Applications in His Specialty for BioSpecifics' XIAFLEX(TM)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LYNBROOK, N.Y., Nov. 3, 2009 (GLOBE NEWSWIRE) -- IPOdesktop.com, in a continuation of its Internet radio interviews featuring BioSpecifics Technologies Corp. (Nasdaq:BSTC), today features an interview with Dr. Eugene Wolf. Dr. Wolf is based in San Francisco, and is a board certified orthopedic surgeon who has practiced in the Bay area for the past 30 years. In the interview, Dr. Wolf says that XIAFLEX may have broad applications within his area of specialization, particularly in frozen shoulder and knee surgery, where XIAFLEX has the potential to shorten the entire healing process.
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
Johnson & Johnson Announces Restructuring Initiatives for Sustainable GrowthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Continues to Invest in Promising Growth Opportunities
Identifies Projected, Annualized, Pre-Tax Cost Savings of $1.4-$1.7
billion Expects to Take Associated Pre-Tax, Restructuring Charge of
$1.1-$1.3 billion in Fourth Quarter of 2009 Confirms...
Source: Drugs.com - Pharma News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Quintiles Announces Clinical Pharmacology Alliance With AstraZenecaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Quintiles today announced that it has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca's clinical pharmacology studies across multiple therapy areas and around the globe.
Source: Pharmaceutical Online News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Viking Systems, Inc. Reports Third Quarter Results; Provides Business UpdatesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WESTBOROUGH, Mass., Nov. 3, 2009 (GLOBE NEWSWIRE) -- Viking Systems, Inc. (OTCBB:VKNG), a supplier of 2D and 3D visualization systems for the medical market, today announced results for the quarter ended September 30, 2009. The Company reported that it has made significant progress in its objective to reach sustainable positive cash flow from operations and that it is exploring strategic and financing options in order to fund anticipated 2010 operating losses while the Company develops and launches its "Next Generation" 3DHD Visualization System. Additionally, the Company discussed a significant order for its current 3Di s...
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
K2M Enters Japanese Spine MarketEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MESA Spinal System Clearance Enables Sale and Distribution in Japan
LEESBURG, Va., Nov. 3--(HSMN NewsFeed)--K2M, Inc., the spinal device company developing innovative and simplified solutions for the treatment of complex spinal pathologies and procedure... Devices, Orthopaedic, NeurosurgeryK2M, MESA Spinal System, spine surgery
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
Study Finds Lack of Diffusible VEGF Growth Factor Can Cause Retinal Defects Similar to Dry Macular DegenerationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Discovery may also have impact on the use of new drugs for
wet macular degeneration
BOSTON, Nov. 2 /PRNewswire-USNewswire/ -- Scientists at Schepens
Eye Research Institute have found that when the eye is missing a
diffusible form of vascular...
Source: Drugs.com - Clinical Trials - November 3, 2009 Category: Pharmaceuticals Source Type: clinical trials
Sanofi Pasteur Presents Safety Data on Menactra Vaccine Given to Infants at Infectious Disease Society MeetingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The two-dose meningococcal quadrivalent conjugate vaccine was
generally well-tolerated
PHILADELPHIA, Nov. 2 /PRNewswire/ -- Sanofi Pasteur, the
vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE:
SNY), presented Safety of a...
Source: Drugs.com - Clinical Trials - November 3, 2009 Category: Pharmaceuticals Source Type: clinical trials
LDR's VerteBRIDGE Plating Technology Reaches New MilestoneEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AUSTIN, Texas, Nov 3--(HSMN NewsFeed)--LDR, a total spine solution company, announced today that since product launch 18 months ago there have been more than 3,000 devices with VerteBRIDGE plating technology implanted worldwide. Over 2,500 of these device... Devices, Orthopaedic, NeurosurgeryLDR Spine, VerteBRIDGE, ROI-A, ROI-C, spine surgery
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
29.10.09: Bonds: EMTN ProgramEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Bonds: EMTN ProgramNew: Supplement dated October 28, 2009 Link to websiteAll changes
Source: Bayer IR Newsfeed: New on this site - November 3, 2009 Category: Pharmaceuticals Source Type: news
ZEVALIN® Receives Positive Reimbursement Ruling Using Average Sales Price (ASP) MethodologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ZEVALIN Was Recently Approved by the FDA for the Treatment Of Patients With Previously Untreated Follicular Non-Hodgkins Lymphoma (NHL), Who Achieve A Partial Or Complete Response To First-Line Chemotherapy
IRVINE, Calif., Nov 3--(HSMN NewsFeed)--Spect... Biopharmaceuticals, Oncology, ReimbursementSpectrum Pharmaceuticals, ZEVALIN, ibritumomab tiuxetan, non-Hodgkins Lymphoma
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
ZEVALIN(R) Receives Positive Reimbursement Ruling Using Average Sales Price (ASP) MethodologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ZEVALIN Was Recently Approved by the FDA for the Treatment Of Patients With Previously Untreated Follicular Non-Hodgkins Lymphoma (NHL), Who Achieve A Partial Or Complete Response To First-Line Chemotherapy
IRVINE, Calif., Nov 3--(HSMN NewsFeed)--Spect... Biopharmaceuticals, Oncology, ReimbursementSpectrum Pharmaceuticals, ZEVALIN, ibritumomab tiuxetan, non-Hodgkins Lymphoma
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer's DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pfizer Inc and Medivation, Inc. recently announced the initiation of CONTACT and CONSTELLATION, two Phase 3 trials of the investigational drug dimebon (latrepirdine)* in patients with moderate-to-severe Alzheimer's disease (AD).
Source: Pharmaceutical Online News - November 3, 2009 Category: Pharmaceuticals Source Type: news
VIVUS Announces Promotion of Peter Tam to PresidentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Tam Also Appointed to VIVUS Board of Directors
MOUNTAIN VIEW, Calif., Nov. 3 (HSMN NewsFeed) -- VIVUS, Inc. (Nasdaq: VVUS ) today announced the promotion of Peter Tam to president of VIVUS. In this position, Mr. Tam will lead and have overall responsi... Biopharmaceuticals, PersonnelVIVUS
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
Symphogen Opens US Operations in Princeton, New JerseyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
US Subsidiary Supports Expanding Opportunities for Symphogens Novel Antibody Pipeline and Discovery and Expression Platforms
COPENHAGEN & PRINCETON, N.J., Nov 3--(HSMN NewsFeed)--Symphogen A/S today announced the opening of its United States headquarte... BiopharmaceuticalsSymphogen
Source: HSMN NewsFeed - November 3, 2009 Category: Pharmaceuticals Source Type: news
Johnson & Johnson Announces Restructuring Initiatives for Sustainable Growth
(Nov 3, 2009)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New Brunswick, NJ (Nov. 3, 2009) – Johnson & Johnson today announced global restructuring initiatives designed to strengthen the company’s position as the world’s leading global health care company. The company is taking steps to prioritize its innovation efforts around the many growth opportunities in health care and to execute aggressively on bringing key new products to market. .....
Source: Johnson and Johnson - November 3, 2009 Category: Pharmaceuticals Source Type: organizations
LHC Group and Twin Lakes Regional Medical Center Announce Home Health Joint VentureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LAFAYETTE, La., Nov. 3, 2009 (GLOBE NEWSWIRE) -- LHC Group, Inc. (Nasdaq:LHCG), one of the largest providers of home health services in the United States, announced today that it has entered into a home health joint venture with Twin Lakes Regional Medical Center in Leitchfield, Kentucky.
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
Trading Outlook for Illumina Inc. Issued by StockPreacher.comEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DALLAS, Nov. 3, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Illumina Inc. (Nasdaq:ILMN). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
Source: Medical News (via PRIMEZONE) - November 3, 2009 Category: Pharmaceuticals Source Type: news
Heart Valve for Boy With Swine FluEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Doctors at Children's Hospital Boston successfully implanted an experimental heart valve in a boy with a congenital heart defect to relieve potentially fatal complications caused by swine flu.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Leading Scientists To Present Work On Powder Flow Measurement And Understanding At One-Day Conference In LondonEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Practice, Theory, Visualisation and Meaning is a one-day conference organised by The Formulation Group of the Royal Society of Chemistry (RSC) in partnership with Freeman Technology and in association with Dechema.
Source: Pharmaceutical Online News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Matsyafed sniffs new biz in nutraceutical domainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Matsyafed has been engaged in the implementation of a broad range of welfare schemes for the fishing community, with the objective of ensuring their socio-economic uplift.
Source: The Economic Times Healthcare and Biotech News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Accentia to tap European marketEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Healthcare receivables cycle management major Accentia Technologies based at the Technopark here has commenced operations from the UK, with the objective of tapping potential markets in Northern Ireland, England and Scotland
Source: The Economic Times Healthcare and Biotech News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Common Pain Relievers May Dilute Power Of Flu ShotsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers -- Advil, Tylenol, aspirin -- at the time of injection may blunt the effect of the shot and have a negative effect on the immune system.
Source: Pharmaceutical Online News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Johnson & Johnson Announces Restructuring Initiatives For Sustainable GrowthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Johnson & Johnson recently announced global restructuring initiatives designed to strengthen the company's position as the world's leading global health care company.
Source: Pharmaceutical Online News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Sikkim turns into a pharma hubEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sikkim, which is the least populous state in the country and the second-smallest after Goa, has already attracted pharma investment upwards of Rs 2,500 crore.
Source: The Economic Times Healthcare and Biotech News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Twice Daily Oral Medication Shows Promise In Treating Patients With Hepatitis CEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
All approved therapy regimens to treat patients with hepatitis C are based on interferon, which must be injected.
Source: Pharmaceutical Online News - November 3, 2009 Category: Pharmaceuticals Source Type: news
ViiV Healthcare launches:
A new specialist HIV company dedicated to delivering advances in HIV treatment and careEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dr Dominique Limet, CEO of ViiV Healthcare, promises 'relentless pursuit' of new treatments
Source: GSK news - November 3, 2009 Category: Pharmaceuticals Source Type: organizations
President of Tanzania and the Abbott Fund Dedicate Modern Emergency Medical DepartmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Abbott.com - November 3, 2009 Category: Pharmaceuticals Source Type: organizations
World's largest Malaria Vaccine Trial Now Underway In Seven African CountriesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A pivotal efficacy trial of RTS,S, the world's most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania.
Source: Pharmaceutical Online News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Air Powered Industrial Vacuum Cleaner For Liquid RecoveryEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The VAC-U-MAX Model TK-01 is a unique industrial vacuum cleaner designed for high-speed transfer of various liquids directly into a closed top 55-gallon drum.
Source: Pharmaceutical Online News - November 3, 2009 Category: Pharmaceuticals Source Type: news
New Twin Stick Dual Chamber Stick Pack DesignEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PTI Packaging Systems recently introduced new Twin Stick, the new innovative design for stick packaging that consists of a dual chamber stick pack to create product combinations such as sugar and spoon, salt and pepper, sugar and coffee creamer, shampoo and conditioner, etc.
Source: Pharmaceutical Online News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Johnson & Johnson Announces Restructuring Initiatives for Sustainable GrowthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Johnson and Johnson Podcasts - November 3, 2009 Category: Pharmaceuticals Source Type: podcasts
Flash Points Linger in Health BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
House Democrats are wrestling with how their health-care bill will deal with abortion and immigration issues as they prepare to bring the bill to the floor.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Home Flu Cures: Bad Medicine?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Amid the frenzy to fight swine flu, folk remedies such as keeping raw onion in the room or eating homemade chicken soup are gaining ground. Melinda Beck asks if any of them actually work.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Flash Points Linger in Health BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
House Democrats are wrestling with how their health-care bill will deal with abortion and immigration issues as they prepare to bring the bill to the floor.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Heart Valve Implanted in Boy With Swine FluEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Doctors at Children's Hospital Boston successfully implanted an experimental heart valve in a boy with a congenital heart defect to relieve potentially fatal complications caused by swine flu.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Is There a Case of the Flu in Your Future?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Imagine if a simple test could tell whether you were going to come down with the flu or a cold even before you get hit by a sore throat, runny nose or fever. Stay tuned, scientists say.
Source: WSJ.com: Health - November 3, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
An FDA Expert on Protecting Yourself Against the FDAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Cerulean's co-founder and managing director, John Avellanet, will reprise his talk from September this coming December in an encore presentation of 'Bulletproof Yourself against FDA Enforcement in 2010'.
"I received at least half a dozen emails from folks who wanted to attend another live event," said Mr Avellanet. "This is probably the most popular webinar and teleconference I give – it fills up every single time."
In ninety minutes Mr Avellanet covers the FDA's directions and priorities for the following year, how firms can identify and mitigate their specific challenges when it comes ...
Source: Drug Development Technology - November 3, 2009 Category: Pharmaceuticals Source Type: info
